The production of the Covid-19 vaccine has taken a different approach through tech transfer by Hester Biosciences and Bharat Biotech teaming up to further start working on this.
On Sunday, Hester already came out with a statement where they announced that the discussions about the vaccine have already started between them and the Bharat Biotech.
The CEO and MD of Hester Biosciences, Rajiv Gandhi said that: ”A triparty consortium has been formed with the Government of Gujarat as the lead partner, to explore the prospects of manufacturing the Covid vaccine through technology from Bharat Biotech.”
Furthermore, Gandhi also said that the discussions are continuing with Bharat Biotech in regards to the technology adjustment process, reviewing the basic facilities at Hester, and the administrative compliances. After the results of the review come clear, that is when the next step will be determined.
Hester Biosciences is a large company, a main player in the animal healthcare section and the second biggest producer of poultry vaccine.
In India, Sputnik V, Covishield and Covaxin are the only vaccines that have been allowed to be sold.
The Prime Minister of India Narendra Modi received a letter from the Delhi Chief Minister Arvind Kejriwal, in which he stated that the Centre should ”share the vaccine formula of the two manufacturers with other capable pharmaceutical companies to scale up the production in the country.”
The Centre can end the dominance on vaccine manufacturing via the patent law, said Kejriwal.